Yûzo Hayashi
- Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment 31
-
- Thyroid Cancer Diagnosis and Treatment 14
- Thyroid Disorders and Treatments 10
- Biochemistry top 2%
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 9
- Cancer-related Molecular Pathways 8
-
- Glutathione Transferases and Polymorphisms 7
- Genomics, phytochemicals, and oxidative stress 6
-
- Sarcoma Diagnosis and Treatment 7
- Co-authors
- Yuji KurokawaMichihito TakahashiFumio FurukawaAkihiko MaekawaSusumu NishimuraHiroshi KasaiHiroshi OnoderaKazuhiro Toyoda
- Partner nations
- JapanUnited StatesSri Lanka
In The Last Decade
Yûzo Hayashi
160 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 137
- Cancer Research 796
- Health, Toxicology and Mutagenesis 533
- Endocrinology, Diabetes and Metabolism 511
- Biochemistry 178
- Oncology 633
Countries citing papers authored by Yûzo Hayashi
This map shows the geographic impact of Yûzo Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yûzo Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yûzo Hayashi more than expected).
Fields of papers citing papers by Yûzo Hayashi
This network shows the impact of papers produced by Yûzo Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yûzo Hayashi. The network helps show where Yûzo Hayashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yûzo Hayashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 4 | |
| 2 | 2008 | 123 | |
| 3 | 2007 | 26 | |
| 4 | 2006 | 19 | |
| 5 | How to dissolve threshold issues for genotoxic carcinogens : View point from risk analysis | 2005 | 1 |
| 6 | 2005 | 3 | |
| 7 | 2003 | 0 | |
| 8 | 2000 | 8 | |
| 9 | 1996 | 12 | |
| 10 | 1994 | 19 | |
| 11 | 1994 | 1 | |
| 12 | Overview of No effect Dose vs No Toxic Effect Dose | 1993 | 0 |
| 13 | 1993 | 77 | |
| 14 | 1993 | 1 | |
| 15 | 1990 | 5 | |
| 16 | 1990 | 30 | |
| 17 | 1987 | 15 | |
| 18 | HEMATOLOGICAL ALTERATIONS INDUCED BY CAPTOPRIL (1-D-3-MERCAPTO-2-METHYL-1-OXOPROPYL-L-PROLINE) IN RATS AND DOGS (The 6th Meeting for the Study of Toxic Effect) | 1979 | 2 |
| 19 | 1979 | 0 | |
| 20 | 1975 | 3 |
About Yûzo Hayashi
Yûzo Hayashi is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 170 papers that have together received 3.5k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (31 papers), Thyroid Cancer Diagnosis and Treatment (14 papers), Thyroid Disorders and Treatments (10 papers), Drug Transport and Resistance Mechanisms (9 papers), Cancer-related Molecular Pathways (8 papers), Glutathione Transferases and Polymorphisms (7 papers), Sarcoma Diagnosis and Treatment (7 papers) and Genomics, phytochemicals, and oxidative stress (6 papers). The work is most often cited by research in Cancer Research (796 citations), Health, Toxicology and Mutagenesis (533 citations) and Endocrinology, Diabetes and Metabolism (511 citations). Yûzo Hayashi has collaborated with scholars based in Japan, United States and Sri Lanka. Frequent co-authors include Yuji Kurokawa, Michihito Takahashi, Fumio Furukawa, Akihiko Maekawa, Susumu Nishimura, Hiroshi Kasai, Hiroshi Onodera, Kazuhiro Toyoda, Takayoshi Imazawa and Michihito Takahashi. Their work appears in journals such as Cancer, Cancer Research and Environmental Health Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.